FLUNITY-HD Cardiovascular Outcomes

HD-IIV consistently reduced severe hospitalization outcomes compared with SD-IIV regardless of prior history of CVD. Among specific CV outcomes¹, HD-IIV conferred a particularly substantial benefit against hospitalization for HF compared with SD-IIV.¹ Moreover, another prespecified analysis supports the use of HD-IIV for reducing both influenza specific and other hospitalization outcomes in older individuals both with and without preexisting ASCVD, with potentially greater absolute benefit among individuals with ASCVD. ²